






























The food we eat has long been linked to the rate we age. 
Selective pressures in times of food abundance and 
scarcity have influenced our very genetic makeup, 
instilling in our genome genes believed to control the 
delicate balance between metabolism and aging. 
However, this balance has been disrupted in western 
societies with developments in agriculture and 
technologies that have promoted the intake of high-
calorie diets and sedentary lifestyles. We are witnessing 
an alarming increase in the rate of metabolic syndrome, 
which consists of a collection of abnormalities 
including obesity, type 2 diabetes, dyslipidemia, fatty 
liver, and a pro-inflammatory and prothrombotic state 
[1, 2] Currently, one in four adults in the United States 
suffers from metabolic syndrome and worldwide 
estimates are over 2.1 billion [3, 4]. Ultimately, this 
epidemic threatens human life-span projections and puts 
great pressure on our already overburdened health care 
system.  
 
The sirtuin family of proteins appears to be at the 
crossroads between nutritional status and longevity. 
Sirtuins are highly conserved NAD
+-dependent protein  
 
 

























































deacetylases and/or ADP ribosyltransferases that target 
histones, transcription factors, and co-regulators to 
adapt gene expression in response to the cellular energy 
state [5]. Many members of this family, including the 
founder Sir2, have been shown to impact aging in 
species ranging from yeast to fly and it is believed these 
protective actions result from the beneficial regulation 
of stress management, and energy homeostasis. SIRT1, 
the mammalian ortholog of Sir2, plays a role in 
numerous physiological processes including fat 
metabolism, glucose homeostasis and immune response. 
Because SIRT1 activity is dependent on the energy 
status of the cell, it provides a direct link between 
metabolism, chromosome structure, and metabolic gene 
regulation [6].  
 
The liver is a central metabolic organ in charge of 
regulating nutrient homeostasis in fed and fasting 
conditions. It controls key aspects of lipid and glucose 
metabolism in response to nutritional and hormonal 
signals [7]. Tight regulation of glucose by the liver is 
essential to ensuring that glucose-dependent tissues 
such as brain and red blood cells have ample energy 
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reports have shown that SIRT1 protein levels and 
enzymatic activity are induced in the fasted liver [8, 9]. 
SIRT1 regulates genes involved in gluconeogenesis 
through deacetylation of several key transcription 
factors and coactivators [8, 9, 10]. The liver also plays 
an important role in maintaining lipid homeostasis. In 
line with its role as a metabolic mediator, SIRT1 is 
known to regulate genes involved in fatty acid oxidation 
and lipolysis [11]. Interestingly, the SIRT1 activator 
resveratrol has shown promise as a therapeutic agent for 
the treatment of metabolic diseases [12, 13]. Mice fed a 
high-fat diet along with resveratrol remained lean and 
healthy compared to over-weight control animals [13]. 
Additionally, resveratrol significantly increased aerobic 
capacity, as evidenced by increased running time and 
elevated oxygen consumption in muscle fibers. 
Resveratrol treatment also protected mice against diet-
induced-obesity and insulin resistance [12]. Groups are 
now focusing on the development of high affinity small 
molecule activators of SIRT1 as a therapeutic approach 
for treating diseases of aging such as type-2 diabetes 
[14]. 
 
Although SIRT1 is an important regulator of 
metabolism, the tissue-specific and systemic roles of 
SIRT1 are difficult to dissect in vivo, primarily due to 
the complicated developmental defects in the SIRT1 
whole-body knockout mouse [15, 16]. In search of 
further evidence to identify a tissue-specific role of 
SIRT1 in the regulation of energy homeostasis, we 
developed a knockout mouse model containing hepatic 
deletion of SIRT1 (LKO) [17]. Microarray analysis of 
liver from LKO mice revealed a striking reduction in 
expression of genes regulated by the peroxisome 
proliferators-activated receptors α (PPARα). This lipid 
sensing nuclear receptor is an important mediator of the 
adaptive response to fasting and starvation.  Deletion of 
SIRT1 in the liver impairs PPARα signaling and 
decreases fatty acid β-oxidation, whereas over-
expression of SIRT1 induces expression of PPARα 
target genes. Furthermore, we found that SIRT1 
regulates PPARα signaling by directly interacting with 
the PPARα nuclear receptor. This interaction appears to 
be ligand dependent, as SIRT1 is recruited to response 
elements on promoters of PPARα target genes by 
agonists as well as by changes of nutritional status. One 
mechanism by which SIRT1 regulates PPARα signaling 
in the liver appears to be through the hands of PGC-1α, 
a key coactivator for PPARα signaling and a direct 
target of SIRT1 [9, 18]. It has been shown that SIRT1 
activates PGC-1α primarily by its deacetylation [9] 
(Figure 2). In keeping with these findings, we observed 

















































LKO livers, PGC-1α protein accumulates on promoter 
regions of PPARα target genes but in a less active 
hyperacetylated form. These findings suggest that 
activated PGC-1α is required for promoting trans-
cription of PPARα targets and that SIRT1 may be 
involved in monitoring the recruitment/dissociation 
cycle of PGC-1α. Additionally, GST-pull down 
Figure  1.  Loss  of  SIRT1  has  minimal  impact  on
gluconeogenesis  in  primary  hepatocytes.  (A)  Glucose





medium  using  a  glucose  oxidase  kit  (Sigma).  Data  represent
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directly interacts with PPARα. Therefore, another 
plausible mechanism underlying our observations is that 
PPARα may be a bona fide SIRT1 substrate. Further 
studies are necessary to elucidate weather SIRT1 indeed 
deacetylates PPARα, thereby affecting its activity.  
 
A major focus of our study was to characterize how 
disruptions in PPARα signaling affect the physiology of 
SIRT1 LKO mice [17]. When challenged with a high-
fat diet, LKO mice displayed increased hepatic steatosis 
and hallmarks of endoplasmic reticulum stress and 
inflammatory responses. Interestingly, in a trend very 
similar to those reported in the PPARα knockout 
mouse, LKO mice displayed elevated levels of 
proinflammatory cytokines. These observations indicate 
that SIRT1 LKO mice are prone to development of 
hepatic inflammation, which has been implicated in the 
progression of insulin resistance [9, 20]. These findings 
provide evidence that solidify SIRT1’s role as a key 
regulator of metabolic homeostasis and complement 
previous animal studies using pharmacological tools 
[14] or modest SIRT1 overexpression mouse models 
[21, 22].  
 
Several of the metabolic abnormalities we observed in 
the SIRT1 LKO mice [17], however, are in direct 




























Using a similar hepatic-specific knockout mouse model,  
Chen et al. observed a reduction in weight gain and 
liver fat accumulation in LKO mice when fed a 
western-style diet. Additionally, their mice were 
protected from the physiological impacts of a western 
diet with lower blood glucose and insulin levels. Similar 
to our study, their group observed minor physiological 
differences in LKO mice fed a chow diet. In wake of 
these findings, Chen et al. proposed that SIRT1 activity 
in the liver is directly proportional to calorie intake, and 
that excess calories and/or SIRT1 activators may result 
in elevated synthesis of fat and cholesterol. One 
possible factor contributing to the discrepancy between 
our observations and those of Chen et al. may be the 
difference in age of animals at which the feeding was 
initiated and data were collected. In our study, mice 
were six-week old when high-fat diet feeding was 
initiated, whereas four-month old mice were utilized in 
the study carried out by Chen et al. The varied responses 
of SIRT1 LKO mice to a western-style diet at different 
ages raises the possibility that hepatic SIRT1 may 
selectively regulate alternative metabolic pathways at 
multiple stages of development. An inducible SIRT1 
knockout model will be helpful to dissect age-dependent 
effects of SIRT1.  Moreover, since the liver is such a 
dynamic metabolic organ, small variations in dietetic 
components and genetic backgrounds may also 
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LKO mice is their normal gluconeogenesis in response 
to a 16-h fasting [17]. The inducible coactivator PGC-
1α is an important component of a number of 
transcriptional complexes that regulate glucose and lipid 
metabolism. Hepatic knockdown of SIRT1 significantly 
abrogates the fasting induction of gluconeogenic genes 
by regulating the acetylation status of PGC1α [11]. 
However, we observed no changes in fasting glucose 
levels in the absence of hepatic SIRT1 despite impaired 
PGC-1α signaling.  Liver specific SIRT1 knockout 
mice had slightly higher, although not statistically 
significant, fasting glucose levels compared to 
littermate controls upon high-fat feeding. Expression 
levels of the two rate-limiting enzymes in the 
gluconeogenic pathway, PEPCK and G-6Pase, were 
also unchanged in the absence of hepatic SIRT1. 
Consistent with these observations, forskolin, an 
intracellular cAMP stimulator, promoted gluconeo-
genesis independently of SIRT1 levels in primary 
hepatocytes (Figure 1A). Additionally, although the 
forskolin-mediated induction of PGC1α expression was 
decreased in these cells (Figure 1B), the overall 
message levels of PEPCK remained similar between 
control and LKO hepatocytes (Figure 1C).   
Gluconeogenesis is regulated by a complex interplay 
between transcription factor and hormonal and co-
regulator signaling. While PGC-1α is known to control 
hepatic glucose production, other factors such as 
FOXO1 and TORC2 are reported to promote gluconeo-
genesis [24]. Interestingly, SIRT1 has been shown to 
deacetylate and repress both FOXO1 [25] and TORC2 
[24]. Therefore, a likely explanation for our findings is 
that while PGC-1α activity is lower in SIRT1 KO 
livers, compensatory effects of FOXO1 and TORC2 
balance the reduction in PGC-1α signaling (Figure 2). 
Another possible explanation for the contradiction in 
these studies may lie in differences in cell types and 
method of SIRT1 deletion/knockdown used in the 
animal studies. It is important to note that the hepatic-
specific albumin-Cre driven SIRT1 knockout mouse 
utilized in our study is a permanent knockout model. 
Phenotypes observed in these mice may reflect systemic 
and local compensatory effects in wake of hepatic 
deletion of SIRT1. Studies done by Rodger et al. [11] 
employed transient knockdown methods using 
adenovirus-mediated shRNA which seem to provoke 
more acute responses to loss of hepatic SIRT1. 
 
In conclusion, while our study defines a new role for 
SIRT1 as a key regulator of hepatic lipid metabolism, it 
also adds fuel to the fire of controversy surrounding this 
protein as a central player in mammalian energy 
homeostasis. It appears that in the liver, a major target 
of this sirtuin is the PPARα/PGC-1α signaling axis. 
Ablation of SIRT1 in the liver creates disruptions in 
fatty acid oxidation, increased cellular stress, and 
elevations in proinflammatory cytokines. What remains 
to be determined is the precise role SIRT1 plays in 
regulating gluconeogenesis and cholesterol metabolism 
in the liver and how this, in turn, affects systemic 
metabolism. Our findings and others suggest that 
activation of SIRT1 may provide a therapeutic strategy 
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